K. Sumiyoshi et al., HLA-DR antigen expression in squamous epithelial dysplasia and squamous cell carcinoma of the esophagus: An immunohistochemical study, ONCOL REP, 6(2), 1999, pp. 301-306
To clarify the biologic significance of esophageal squamous epithelial dysp
lasia, especially the similarity to carcinoma in situ, immunohistochemical
investigation of HLA-DR antigen expression and lymphocyte infiltration was
performed. HLA-DR antigen was expressed in 12 of the 35 invasive carcinomas
(34.4%), 23 of the 38 intraepithelial carcinomas (60.5%), 21 of the 50 are
as of dysplasia (42.0%) and only 2 of the 625 specimens of non-cancerous sq
uamous epithelium (0.3%). The HLA-DR-positive rate of dysplasia localized c
ontinuous to HLA-DR-positive carcinoma was 68.4%, which was significantly h
igher than that for HLA-DR positive dysplasia localized continuous to HLA-D
R negative cancer (11.1%) (p<0.05). In areas of dysplasia and intraepitheli
al carcinoma, T cell infiltration was significantly increased at the sites
of HLA-DR antigen expression (P<0.01). B cell infiltration was also more co
mmon in areas of positive expression. These results suggest that HLA-DR ant
igen is associated with the local immune response to squamous epithelial dy
splasia, and that HLA-DR antigen expression may prevent tumor invasion simi
larly to its role in intraepithelial carcinoma.